Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01056380Phase 2Terminated
A Phase 2 trial of nitazoxanide in influenza, sponsored by Romark Laboratories. Started Jan 2010; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01056380.